com has added a new market research report: Global Markets and Technologies for Advanced Drug Delivery Systems
Demand for drug delivery systems
in the US, consisting of specialized pharmaceutical dosage formulations as well as medical supplies, devices and equipment used to administer pharmaceuticals, will increase over nine percent annually to $67 billion in 2005.
com/research/04e549/market_for_drug_de) has announced the addition of the "Market for Drug Delivery Systems
in the US" report to their offering.
The market for pulmonary drug delivery systems
has been segmented into three major product types, namely, metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers.
today announced expansion plans for its Cedar Park (Greater Austin), Texas R&D center to include clinical manufacturing operations for ophthalmic and intranasal drug delivery systems
and pharmaceutical products under development by the company.
com announces that a new market research report is available in its catalogue Global Markets and Technologies for Advanced Drug Delivery Systems
-- Focus on End Users http://www.
Drug delivery systems
are mechanisms by which therapeutic agents are introduced into the body, and directed in a controlled way towards a target organ or site of action.
REASONS FOR DOING THIS STUDY Extensive research in the field of various drug delivery systems
has revealed their specific functionality in improving the transportation of a pharmaceutical compound in the body as desired to safely achieve its anticipated therapeutic effect.
SUMMARY TABLE GLOBAL REVENUE OF ADVANCED DRUG DELIVERY SYSTEMS
,BYREGION, THROUGH 2018 ($ MILLIONS) 7SUMMARY FIGURE GLOBAL REVENUE OF ADVANCED DRUG DELIVERY SYSTEMS
,BYREGION, 2011-2018 ($ MILLIONS) 7
The dose ranging and the long-term safety and efficacy studies will be used to support the filing of a "modified" New Drug Application (NDA), intended for certain changes in existing approved drug products, such as changes in drug formulation or drug delivery systems
28 /PRNewswire/ -- At a session of the Drug Delivery Systems
Conference being held here for pharmaceutical executives, Thomas Spencer, executive vice president and chief technical officer of Pharma Patch plc, presented findings of research which produced a new transdermal drug delivery technology.
The Company's proprietary drug delivery systems
improve the efficacy of drugs by regulating the dosage so as to ease administration, increase absorption, enhance bioavailability and control the time and place of release.